Addus HomeCare Corporation (ADUS)

NasdaqGS • Currently down 2.50 (-1.97%) in today's trading session

1 member of Congress has disclosed 2 trades in Addus HomeCare Corporation (ADUS) via STOCK Act filings. The most recent disclosure was a sale by Donna E. Shalala on 24 June 2019. Aggregate disclosed activity totals roughly $16K in sales (midpoint estimates from bracketed disclosure amounts).

Addus HomeCare Corporation is currently trading at $124.31, positioned at 83% of its 52-week range ($87.95 – $131.59).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$124.31
24h Change
-2.50 (-1.97%)
52 Week Range
$87.95–$131.59
View on NASDAQ

Addus HomeCare Corporation Price History and Technical Analysis

Congressional Trading Activity for ADUS

Select to highlight on chart
2 transactions
Compliance: 50%
Donna E. Shalala24 Jun 201927 Apr 2020SaleStock$1,001 - $15,000N/A
Donna E. Shalala24 Jun 201921 Jul 2020SaleStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$2.32B

Volume

276.63K

Beta

0.75

P/E Ratio

18.61

Fundamentals

EPS

$6.68

Div. Yield

-

Open

$124.59

Day Range

$123.64 – $125.91

Company Information

Sector
Healthcare
Industry
Medical - Care Facilities
Exchange
NASDAQ · USD
Country
US
CEO
R. Dirk Allison
IPO Date
2009-10-28
Website
addus.com

Addus HomeCare Corporation, through its various subsidiaries, offers essential personal support services across the United States. The company primarily assists seniors, individuals with chronic illnesses or disabilities, and those at risk of hospita...

Earnings

Next Report

Q4 2026

22 Feb

EPS Est.

$1.90

Rev. Est.

$394.9M

Days Until

105

Recent Quarters

Q3 20263 Nov
EPS$1.83
Beat 2.2%
Q2 20263 Aug
EPS$1.73
Beat 1.8%
Q1 20264 May
EPS$1.62
Beat 6.6%
Q4 202523 Feb
EPS$1.77
Beat 3.5%
Q3 20253 Nov
EPS$1.56
Beat 2.0%
Q2 20254 Aug
EPS$1.49
Beat 2.8%
Q1 20255 May
EPS$1.42
Beat 6.8%
Q4 202424 Feb
EPS$1.38
Beat 2.2%
Q3 20244 Nov
EPS$1.30
Beat 1.6%
Q2 20245 Aug
EPS$1.35
Beat 11.6%
Q1 20246 May
EPS$1.21
Beat 11.0%
Q4 202326 Feb
EPS$1.32
Beat 12.8%
Q3 202330 Oct
EPS$1.15
Beat 6.5%
Q2 202331 Jul
EPS$1.07
Beat 5.9%
Q1 20231 May
EPS$0.97
Beat 10.2%
Q4 202227 Feb
EPS$1.11
Beat 16.8%
Q3 202231 Oct
EPS$0.94
Beat 1.1%
Q2 20221 Aug
EPS$0.91
Beat 1.1%
Q1 20222 May
EPS$0.77
Beat 1.3%
Q4 202124 Feb
EPS$0.97
Beat 5.4%
Q3 20211 Nov
EPS$0.91
Beat 2.3%
Q2 20212 Aug
EPS$0.90
Beat 1.1%
Q1 20213 May
EPS$0.74
Beat 0.0%
Q4 202025 Feb
EPS$0.82
Beat 9.3%
Q3 20202 Nov
EPS$0.76
Beat 16.9%
Q2 202010 Aug
EPS$0.73
Beat 43.1%
Q1 20204 May
EPS$0.77
Beat 20.3%
Q4 201917 Mar
EPS$0.73
Beat 9.0%
Q3 20194 Nov
EPS$0.62
Beat 6.9%
Q2 20195 Aug
EPS$0.56
Beat 3.7%
Q1 20196 May
EPS$0.52
Beat 13.0%
Q4 20184 Mar
EPS$0.55
Beat 7.8%
Q3 20185 Nov
EPS$0.48
Beat 4.3%
Q2 20186 Aug
EPS$0.50
Miss 2.0%
Q1 20187 May
EPS$0.42
Beat 7.7%
Q4 20175 Mar
EPS$0.46
Beat 4.5%
Q3 20176 Nov
EPS$0.42
Beat 0.0%
Q2 20177 Aug
EPS$0.38
Beat 2.7%
Q1 20178 May
EPS$0.34
Beat 3.0%
Q4 20166 Mar
EPS$0.43
Beat 13.2%
Q3 20167 Nov
EPS$0.39
Beat 25.8%
Q2 20161 Aug
EPS$0.31
Beat 0.0%
Q1 20162 May
EPS$0.28
Beat 0.0%
Q4 20157 Mar
EPS$0.29
Beat 0.0%
Q3 20152 Nov
EPS$0.25
Beat 0.0%
Q2 20153 Aug
EPS$0.30
Miss 3.2%
Q1 201530 Apr
EPS$0.24
Beat 0.0%
Q4 20145 Mar
EPS$0.36
Beat 20.0%
Q3 201430 Oct
EPS$0.29
Beat 0.0%
Q2 201431 Jul
EPS$0.25
Beat 4.2%
Q1 20141 May
EPS$0.21
Beat 10.5%
Q4 201312 Mar
EPS$0.28
Beat 7.7%
Q3 20137 Nov
EPS$0.25
Beat 8.7%
Q2 20131 Aug
EPS$0.25
Beat 13.6%
Q1 20132 May
EPS$0.20
Beat 42.9%
Q4 201213 Mar
EPS$0.35
Beat 66.7%
Q3 20121 Nov
EPS$0.17
Beat 0.0%
Q2 20122 Aug
EPS$0.14
Beat 27.3%
Q1 20123 May
EPS$0.07
Miss 30.0%
Q4 20111 Mar
EPS$0.35
Beat 105.9%
Q3 20113 Nov
EPS$0.17
Beat 0.0%
Q2 20114 Aug
EPS$0.12
Beat 9.1%
Q1 20115 May
EPS$0.08
Miss 11.1%
Q4 20103 Mar
EPS$0.14
Beat 0.0%
Q3 20104 Nov
EPS$0.15
Beat 36.4%
Q2 20105 Aug
EPS$0.16
Beat 0.0%
Q1 201013 May
EPS$0.13
Miss 7.1%
Q4 200927 Mar
EPS$-0.17
Q4 200918 Mar
EPS$0.07
Miss 65.0%
Q1 200930 Jun
EPS$0.37
Q4 200831 Mar
EPS$1.22
Q3 200831 Dec
EPS$0.98
Q2 200830 Sept
EPS$0.26

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about ADUS

Which members of Congress have traded ADUS?
1 member of Congress has disclosed 2 trade in Addus HomeCare Corporation (ADUS) under the STOCK Act: Donna E. Shalala.
When was ADUS most recently disclosed by Congress?
The most recent ADUS disclosure was a sale by Donna E. Shalala on 24 June 2019.
What is the total disclosed congressional trading volume for ADUS?
Members of Congress have disclosed approximately $16K in ADUS sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in ADUS?
This ADUS page updates as soon as new STOCK Act disclosures are filed for Addus HomeCare Corporation. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.